TD SYNNEX reported a solid Q3 2024 despite margin headwinds largely tied to Hyve-related mix shifts and prior-year atypical profit benefits. Total gross billings rose 9% year over year to $20.3 billion, ahead of the high end of management’s guidance, while GAAP revenue was $14.6847 billion. Non-GAAP gross profit stood at $961 million (4.7% of gross billings), and non-GAAP operating income was $393 million (1.9% of gross billings). Net income was $178.6 million with a GAAP EPS of $2.09 and non-GAAP EPS of $2.86. The quarter showcased breadth of growth across Endpoint and Advanced Solutions, with Hyve driving a meaningful portion of the margin mix shift. Management signaled continued IT market recovery and increased investment in growth platforms, including AI-centric initiatives, services expansion, and onshore capabilities, while maintaining a disciplined capital-allocation stance.
For Q4, TD SYNNEX guided non-GAAP gross billings of $20.5–$21.5 billion (about 6% midpoint growth) and reported revenue of $14.9–$15.7 billion. Non-GAAP net income was guided to $239–$282 million, with diluted EPS of $2.80–$3.30. The company projects roughly $1.0 billion of free cash flow for FY2024 and reiterated a commitment to returning excess cash to shareholders (dividends and buybacks) while funding strategic growth. The near-term outlook remains constructive, anchored by AI-driven demand in Strategic Technologies (cloud, security, AI) and ongoing geographic expansion (Europe, APJ) that should gradually improve gross margins as mix shifts away from high-tying Hyve cost structures toward higher-margin services and North American contributions.
Key takeaways for investors are: (1) TD SYNNEX is navigating a transition toward higher-value services and AI-enabled solutions, (2) Hyve remains a meaningful growth vehicle but creates near-term margin headwinds that management expects to moderate as the mix shifts and North American profitability improves, and (3) a balanced capital-allocation approach remains intact, with a bias toward buybacks in Q4 while maintaining the capacity to fund organic growth and potential selective M&A in the future.